Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Return on Assets: 2009-2025

Historic Return on Assets for Aytu Biopharma (AYTU) over the last 14 years, with Sep 2025 value amounting to 0.02%.

  • Aytu Biopharma's Return on Assets rose 4.00% to 0.02% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02%, marking a year-over-year increase of 4.00%. This contributed to the annual value of 0.01% for FY2025, which is 3.00% up from last year.
  • According to the latest figures from Q3 2025, Aytu Biopharma's Return on Assets is 0.02%, which was up 254.36% from 0.00% recorded in Q2 2025.
  • Over the past 5 years, Aytu Biopharma's Return on Assets peaked at 0.02% during Q3 2025, and registered a low of -0.71% during Q2 2022.
  • In the last 3 years, Aytu Biopharma's Return on Assets had a median value of -0.03% in 2024 and averaged -0.06%.
  • In the last 5 years, Aytu Biopharma's Return on Assets tumbled by 49bps in 2022 and then spiked by 59bps in 2023.
  • Aytu Biopharma's Return on Assets (Quarterly) stood at -0.37% in 2021, then dropped by 16bps to -0.53% in 2022, then surged by 44bps to -0.09% in 2023, then grew by 7bps to -0.01% in 2024, then increased by 4bps to 0.02% in 2025.
  • Its Return on Assets was 0.02% in Q3 2025, compared to 0.00% in Q2 2025 and -0.01% in Q1 2025.